Guangdong Marubi Biotechnology Stock Return On Equity
603983 Stock | 27.63 0.18 0.65% |
Guangdong Marubi Biotechnology fundamentals help investors to digest information that contributes to Guangdong Marubi's financial success or failures. It also enables traders to predict the movement of Guangdong Stock. The fundamental analysis module provides a way to measure Guangdong Marubi's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guangdong Marubi stock.
Guangdong | Return On Equity |
Guangdong Marubi Biotechnology Company Return On Equity Analysis
Guangdong Marubi's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Guangdong Marubi Return On Equity | 0.1 |
Most of Guangdong Marubi's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangdong Marubi Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Guangdong Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Guangdong Marubi Biotechnology has a Return On Equity of 0.1014. This is 96.16% lower than that of the Personal Care Products sector and 99.31% lower than that of the Consumer Staples industry. The return on equity for all China stocks is 132.71% lower than that of the firm.
Guangdong Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guangdong Marubi's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guangdong Marubi could also be used in its relative valuation, which is a method of valuing Guangdong Marubi by comparing valuation metrics of similar companies.Guangdong Marubi is currently under evaluation in return on equity category among its peers.
Guangdong Fundamentals
Return On Equity | 0.1 | ||||
Return On Asset | 0.039 | ||||
Profit Margin | 0.12 % | ||||
Operating Margin | 0.10 % | ||||
Current Valuation | 9.55 B | ||||
Shares Outstanding | 401 M | ||||
Shares Owned By Insiders | 80.79 % | ||||
Shares Owned By Institutions | 7.46 % | ||||
Price To Book | 3.30 X | ||||
Price To Sales | 4.22 X | ||||
Revenue | 2.23 B | ||||
Gross Profit | 1.14 B | ||||
EBITDA | 277.35 M | ||||
Net Income | 259.42 M | ||||
Total Debt | 100.07 M | ||||
Book Value Per Share | 8.42 X | ||||
Cash Flow From Operations | 338.02 M | ||||
Earnings Per Share | 0.82 X | ||||
Target Price | 31.19 | ||||
Number Of Employees | 1.1 K | ||||
Beta | 0.21 | ||||
Market Capitalization | 11.16 B | ||||
Total Asset | 4.45 B | ||||
Retained Earnings | 1.99 B | ||||
Working Capital | 1.52 B | ||||
Net Asset | 4.45 B | ||||
Last Dividend Paid | 0.52 |
About Guangdong Marubi Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guangdong Marubi Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangdong Marubi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangdong Marubi Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Guangdong Stock
Guangdong Marubi financial ratios help investors to determine whether Guangdong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangdong with respect to the benefits of owning Guangdong Marubi security.